SciVac Ltd.

SciVac Ltd. is a dynamic biopharmaceutical company dedicated to the development, production, and marketing of life-saving recombinant human healthcare biotechnology products. Focusing on endocrinology, gastroenterology, and immunology, SciVac Ltd. is committed to advancing healthcare solutions and improving patient outcomes worldwide.

SciVac's flagship product, Sci-B-Vac®, stands as the only commercially available 3rd generation Hepatitis B vaccine. Demonstrating superior performance in clinical trials, Sci-B-Vac® offers significant advantages over competing vaccines in the fight against the Hepatitis B virus (HBV). SciVac Ltd. is dedicated to innovation and excellence in biotechnology, making a tangible difference in global health.

In addition to its product offerings, SciVac Ltd. provides contract development and manufacturing services to the Life-science and Biotech markets. With state-of-the-art facilities and extensive expertise, SciVac facilitates the co-development of therapeutic proteins through upstream and downstream processes, ensuring effective and rapid technical transfers. SciVac also maintains strategic collaborations with partners and institutions to continuously enhance its pipeline. We invite SciVac Ltd.’s management team to create a customized and exclusive company showcase and product listing on our platform to further highlight their capabilities and achievements.